Dana Investment Advisors, Inc. Baxter International Inc Transaction History

Dana Investment Advisors, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$75.39 - $82.36 $1.49 Million - $1.63 Million	-19,805 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$78.33 - $90.73 $128,696 - $149,069	-1,643 Reduced 7.66%	19,805 $1.59 Million
Q2 2020 Aug 11, 2020	BUY	$78.66 - $94.14 $9,203 - $11,014	117 Added 0.55%	21,448 $1.85 Million
Q1 2020 May 13, 2020	SELL	$71.57 - $93.3 $40,079 - $52,248	-560 Reduced 2.56%	21,331 $1.73 Million
Q4 2019 Feb 11, 2020	SELL	$76.7 - $88.45 $2.02 Million - $2.33 Million	-26,378 Reduced 54.65%	21,891 $1.83 Million
Q3 2019 Nov 12, 2019	SELL	$81.4 - $89.78 $331,705 - $365,853	-4,075 Reduced 7.79%	48,269 $4.22 Million
Q2 2019 Aug 13, 2019	SELL	$73.44 - $82.41 $9.39 Million - $10.5 Million	-127,823 Reduced 70.95%	52,344 $4.29 Million
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $1.48 Million - $1.87 Million	-22,989 Reduced 11.32%	180,167 $14.6 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $1.79 Million - $2.26 Million	-29,111 Reduced 12.53%	203,156 $13.4 Million
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $18.3 Million - $20.1 Million	-258,873 Reduced 52.71%	232,267 $17.9 Million
Q2 2018 Aug 01, 2018	SELL	$63.43 - $75.41 $2.14 Million - $2.54 Million	-33,725 Reduced 6.43%	491,140 $0
Q1 2018 May 15, 2018	SELL	$62.56 - $72.26 $1.56 Million - $1.8 Million	-24,894 Reduced 4.53%	524,865 $34.1 Million
Q4 2017 Feb 13, 2018	SELL	$61.45 - $66.05 $640,186 - $688,108	-10,418 Reduced 1.86%	549,759 $0
Q3 2017 Nov 15, 2017	BUY	$59.5 - $64.61 $33.3 Million - $36.2 Million	560,177	560,177 $35.2 Million

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.